Cholangioscope Market Introduction

Cholangioscope is a device used for non-invasive endoscopic procedure for direct visual diagnostic evaluation of the bile ducts. Cholangioscopy is performed when endoscopic retrograde cholangiopancreatography is not sufficient to provide a clear diagnostic image. Reaction to sedatives, sore throat, gas, and cramps are some of the side effects of cholangioscope. 

Cholangioscope Market - Competitive Landscape

Key players operating in the global cholangioscope market are Arthrex, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical, Inc., Medtronic plc, Johnson & Johnson, FUJIFILM Holdings Corporation, HOYA Corporation, KARL STORZ GmbH & Co. KG, and Olympus Corporation. Suppliers in the global cholangioscope market include manufacturers of components of various electronic devices such as visualization systems, energy devices, and other medical grade devices. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global market during the forecast period. Additionally, strong product portfolio, high brand recognition, and wide geographic presence are likely to propel the global cholangioscope market during the forecast period. The global market for cholangioscope is highly competitive, with presence of large number of players facing cut throat price competition from small distributors and local players. Various organizations also offer original equipment manufacturing (OEM) services. This has enabled global companies to meet local demand. 

Identify the key factors that will drive your company’s growth, Request a brochure of this report here 


KARL STORZ GmbH & Co. KG is one of the leading medical devices companies which designs, manufactures and sells endoscopic equipment for cholangioscopy, arthroscopy, laparoscopy, gynecology, urology, and others. The company also offers product range in veterinary and industrial application. The company majorly operates in Europe and North America. KARL STROZ is a privately held company and is headquartered in Tuttlingen, Germany. 

Olympus Corporation

Olympus Corporation is a global company with expertise in imaging techniques. The company operates in the business segments which include medical, life science and industrial, imaging, information and communication, and others. In medical segment, the company provides endoscopic imaging, endoscopic ultrasound, and catheters and newly introduced capsule endoscope. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in the year 2003. The company was incorporated in 1919 and is headquartered in Tokyo, Japan. 

Cholangioscope Market Dynamics

The global cholangioscope market is driven by various factors at regional, national, as well as global level. Aging population and increase in trend of minimally invasive surgeries are the major factors contributing to the growth of the global market. Moreover, surge in technological innovations and investment by public and private sectors for the advancement of health care are projected to propel the global market during the forecast period. However, high cost of cholangioscope devices and lack of skilled surgeons are likely to restrain the global market during the forecast period. Cholangioscope requires highly sophisticated technology and expertise in manufacturing and adding technological advancements in it. These factors increase the overall cost of cholangioscope and accessories. This acts as a major restraint of the global cholangioscope market. 

Expanding operations in future? To get the perfect launch ask for a custom report here

Technological Innovations are driving the Cholangioscope Market

Technological innovations in medical cholangioscope have increased the scope of the market and therefore increased the customer base. For instance, in 2015, Boston Scientific launched SpyGlass DS II Direct Visualization System which provides high resolution imaging during cholangiopancreatography procedure.

Less Number of Skilled Professionals would Restraint the Market for Cholangioscope

Cholangioscope requires highly sophisticated technology and extreme expertise in manufacturing and adding technological advancements. Low awareness, high cost of technology and huge gap in number of physicians available for population, there is always scarcity of trained healthcare professional for handling endoscopic devices. According to World Bank data, in 2010 there were 2.4 and 2.7 physicians per 1,000 people in the United States and United Kingdom whereas China, India and Indonesia have 1.8, 0.6 and 0.3 physicians including general and specialist medical practitioners respectively. Brazil and Mexico have 1.8 and 2.0 physicians per 1,000 people respectively. Lesser number of physicians in emerging and developing market forms major restraint for the growth of cholangioscope market.

Cholangioscope Market Segmentation

Based on the product type, the cholangioscope market is segmented into

  • Diagnostic
    • 2-dimentional
    • 3-dimentional
  • Therapeutic
    • 2-dimentional
    • 3-dimentional

Based on the distribution channel, the cholangioscope market is segmented into

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Others

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Cholangioscope Market

Pre Book